Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Post by FactFinder1994on Feb 24, 2022 10:27am
116 Views
Post# 34457861

Questions that only diagnostics can answer....

Questions that only diagnostics can answer...."It's so soon after that initial BA.1 peak that you have a lot of people who were either vaccinated or boosted ... [or] got Omicron, and so right now all of those people will have relatively high titers of antibodies, neutralizing antibodies that will protect against infection," Rasmussen says.  Question is....how long before the amount of neutralizing antibodies remain high enough to protect against infection?  The answer will be different for everyone, so a high quality antibody test is of significant value both on an individual level and for society at large.  

CTV NewsNew studies bring BA.2 variant into sharper focusOn the heels of concerning new lab and animal experiments suggesting that BA.2 may be capable of causing more severe disease than the....17 hours ago
<< Previous
Bullboard Posts
Next >>